250 related articles for article (PubMed ID: 18775435)
1. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
Chen S; O'Reilly LP; Smithgall TE; Engen JR
J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
[TBL] [Abstract][Full Text] [Related]
2. The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
Chen S; Brier S; Smithgall TE; Engen JR
Protein Sci; 2007 Apr; 16(4):572-81. PubMed ID: 17327393
[TBL] [Abstract][Full Text] [Related]
3. Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity.
Meyn MA; Wilson MB; Abdi FA; Fahey N; Schiavone AP; Wu J; Hochrein JM; Engen JR; Smithgall TE
J Biol Chem; 2006 Oct; 281(41):30907-16. PubMed ID: 16912036
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
5. Abl N-terminal cap stabilization of SH3 domain dynamics.
Chen S; Dumitrescu TP; Smithgall TE; Engen JR
Biochemistry; 2008 May; 47(21):5795-803. PubMed ID: 18452309
[TBL] [Abstract][Full Text] [Related]
6. Enhanced SH3/linker interaction overcomes Abl kinase activation by gatekeeper and myristic acid binding pocket mutations and increases sensitivity to small molecule inhibitors.
Panjarian S; Iacob RE; Chen S; Wales TE; Engen JR; Smithgall TE
J Biol Chem; 2013 Mar; 288(9):6116-29. PubMed ID: 23303187
[TBL] [Abstract][Full Text] [Related]
7. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
8. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
[TBL] [Abstract][Full Text] [Related]
9. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
Mayer BJ; Baltimore D
Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
[TBL] [Abstract][Full Text] [Related]
10. An intramolecular SH3-domain interaction regulates c-Abl activity.
Barilá D; Superti-Furga G
Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
[TBL] [Abstract][Full Text] [Related]
11. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
[TBL] [Abstract][Full Text] [Related]
12. Intramolecular interactions of the regulatory domains of the Bcr-Abl kinase reveal a novel control mechanism.
Nam HJ; Haser WG; Roberts TM; Frederick CA
Structure; 1996 Sep; 4(9):1105-14. PubMed ID: 8805596
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.
Alvarado JJ; Betts L; Moroco JA; Smithgall TE; Yeh JI
J Biol Chem; 2010 Nov; 285(46):35455-61. PubMed ID: 20810664
[TBL] [Abstract][Full Text] [Related]
14. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions.
Merő B; Radnai L; Gógl G; Tőke O; Leveles I; Koprivanacz K; Szeder B; Dülk M; Kudlik G; Vas V; Cserkaszky A; Sipeki S; Nyitray L; Vértessy BG; Buday L
J Biol Chem; 2019 Mar; 294(12):4608-4620. PubMed ID: 30659095
[TBL] [Abstract][Full Text] [Related]
17. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
Li S; Couvillon AD; Brasher BB; Van Etten RA
EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
[TBL] [Abstract][Full Text] [Related]
19. Two-state dynamics of the SH3-SH2 tandem of Abl kinase and the allosteric role of the N-cap.
Corbi-Verge C; Marinelli F; Zafra-Ruano A; Ruiz-Sanz J; Luque I; Faraldo-Gómez JD
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3372-80. PubMed ID: 23959873
[TBL] [Abstract][Full Text] [Related]
20. Biochemical properties of the Cdc42-associated tyrosine kinase ACK1. Substrate specificity, authphosphorylation, and interaction with Hck.
Yokoyama N; Miller WT
J Biol Chem; 2003 Nov; 278(48):47713-23. PubMed ID: 14506255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
